ORYZON Presents Preliminary Dose Finding Results of Phase II Trial With Iadademstat in AML
Results presented at 24th Congress of EHA in Amsterdam Combination of iadademstat and azacitidine shows good safety profile in elderly AML patients Recommended dose for Phase II established with only six patients Quick onset of response and preliminary …